A Study Into Systemic and Oral Levels of Proinflammatory Biomarkers Associated With Endpoints After Active Non‐Surgical Periodontal Therapy
Journal of Clinical Periodontology · 2025
DOI: 10.1111/jcpe.14089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, 2025. Verfasst von Nils Werner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Conservative Dentistry and Periodontology, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Gingival Crevicular Fluid, Periodontitis, Inflammation Mediators, Chronic Periodontitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aim
To analyse whether some selected inflammatory biomarkers collected from venous blood and gingival crevicular fluid (GCF) were associated with the outcome of non‐surgical periodontal therapy. Materials and Methods Two‐hundred and nine patients affected by periodontitis were enrolled in the study, who had undergone steps I and II therapy as well as a non‐surgical re‐instrumentation (NSRI) of periodontal pockets after 6 months. Serum (SE), plasma (PL) and GCF samples were quantitatively analysed for the following inflammatory biomarkers: active matrix metalloproteinase‐8 (aMMP‐8), prostaglandin E2 (PGE2) and surfactant protein D (SP‐D). Therapy outcomes were evaluated using a ‘treat‐to‐target’ endpoint (T2T) at the patient level, defined as ≤ 4 sites with pocket depth ≥ 5 mm.
Results
Patients presented with 23 ± 6 teeth (mean ± SD) at baseline. After steps I and II therapy, 41.6% of the patients reached T2T and after NSRI 47.4%. Univariate analysis identified a potential association between high levels of PL‐SP‐D and more favourable treatment outcomes. Multivariate binary logistic regression adjusted for sex, mean baseline probing depth, diabetes and current smoking status confirmed an independent relationship between baseline PL‐SP‐D and the T2T after steps I and II therapy (aOR 0.432, p = 0.011), implying that a higher level PL‐SP‐D at baseline is associated with a > 50% reduced risk of failing T2T. However, no such association was found for PL‐SP‐D and NSRI.
Conclusion
Higher baseline PL‐SP‐D levels might be associated with more favourable treatment outcomes after steps I and II therapy. This may be due to its role in the regulation of neutrophil function. However, further investigation is required to confirm this hypothesis. If proven, PL‐SP‐D could play a role as a biomarker for identifying individuals who respond differentially to primary therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Conservative Dentistry and Periodontology, LMU University Hospital, LMU Munich, Munich, Germany.
- Department of Dermatology and Allergology, LMU University Hospital, LMU Munich, Munich, Germany.
- Private Practice.
ORCID-Profile: Nils Werner, Iris Frasheri, Caspar Victor Bumm
Zitieren
APA
Werner, N., Frasheri, I., Heck, K., Scalia, C., Pitchika, V., Summer, B., Ern, C., Heym, R., Schwendicke, F., Bumm, C. V., & Folwaczny, M. (2025). A Study Into Systemic and Oral Levels of Proinflammatory Biomarkers Associated With Endpoints After Active Non‐Surgical Periodontal Therapy. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.14089
Vancouver
Werner N, Frasheri I, Heck K, Scalia C, Pitchika V, Summer B, et al. A Study Into Systemic and Oral Levels of Proinflammatory Biomarkers Associated With Endpoints After Active Non‐Surgical Periodontal Therapy. Journal of Clinical Periodontology. 2025. doi:10.1111/jcpe.14089
BibTeX
@article{Werner2025,
author = {Werner, Nils and Frasheri, Iris and Heck, Katrin and Scalia, Carla and Pitchika, Vinay and Summer, Burkhard and Ern, Christina and Heym, Richard and Schwendicke, Falk and Bumm, Caspar Victor and Folwaczny, Matthias},
title = {A Study Into Systemic and Oral Levels of Proinflammatory Biomarkers Associated With Endpoints After Active Non‐Surgical Periodontal Therapy},
journal = {Journal of Clinical Periodontology},
year = {2025},
doi = {10.1111/jcpe.14089}
}
EUVIMED